Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/1999
12/08/1999EP0961793A1 Polymers incorporating peptides
12/08/1999EP0961782A1 Human tumor necrosis factor receptor-like 2
12/08/1999EP0961780A1 Protein markers for lung cancer and use thereof
12/08/1999EP0961778A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
12/08/1999EP0961547A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM)
12/08/1999EP0628078B1 Multivalent single chain antibodies
12/08/1999EP0606280B1 New conjugates for the introduction of nucleic acid into higher eukaryotic cells
12/08/1999EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999CN1238013A Method for detection of metastatic prostate cancer
12/08/1999CN1237983A Antibody against human parathormone related peptides
12/08/1999CN1237982A Soluble polypeptides
12/08/1999CN1237911A Optical diagnostic agents for diagnosis of neurodenerative diseases by means of near infra-red radiation (NIR-Radiation)
12/08/1999CN1237910A Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies
12/07/1999US5998599 Growth arrest gene compositions and methods
12/07/1999US5998587 Anti-cyanovirin antibody
12/07/1999US5998586 Interleukin-5 specific recombinant antibodies
12/07/1999US5998585 Antibodies to the cell division protein SPA-1
12/07/1999US5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/07/1999US5998583 BH3 interacting domain death agonist
12/07/1999US5998582 D-type cyclins and uses related thereto
12/07/1999US5998577 Method for determining mimotopes
12/07/1999US5998378 Compounds having proteolytic inhibitory activity useful for treating diseases, particularly as applied to the treatment of sepsis, aids or autoimmune diseases, resulting from a decrease in the circulating level of mature protein hormones
12/07/1999US5998372 Zinc ring protein
12/07/1999US5998172 Anti-CD6 ligand antibodies
12/07/1999US5998165 Polynucleotides encoding a protein associated with pancreatic cancer
12/07/1999US5998154 Somatostatin receptor peptide antigens and antibodies
12/07/1999US5998151 Pretreatment measurement of solid tumor sample; calibration
12/07/1999US5998144 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/07/1999US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses
12/07/1999US5997868 Inhibition of scatter factor for blocking angiogenesis
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999US5997866 Panel of antibodies for detecting cadherins, catenins and plaque proteins in tissues and method of using the panel
12/07/1999US5997865 Agonist antibodies against the flk2/flt3 receptor and uses thereof
12/07/1999US5997861 Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
12/07/1999CA2116764C Immunoreactive hepatitis c virus polypeptide compositions
12/07/1999CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
12/07/1999CA1340838C Coccidiosis vacine
12/02/1999WO1999061918A1 Method and means for caries prevention and susceptibility detection
12/02/1999WO1999061913A2 Improvements in or relating to diagnosis and treatment of bacterial infections
12/02/1999WO1999061909A2 Methods and compositions for the detection of human herpesvirus
12/02/1999WO1999061629A1 Cell separation device and separation method
12/02/1999WO1999061628A2 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
12/02/1999WO1999061626A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999WO1999061625A1 Mycobacterial n-acetyltransferases
12/02/1999WO1999061620A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999WO1999061618A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999WO1999061617A1 Interleukins-21 and 22
12/02/1999WO1999061615A1 Kunitz domain polypeptide and materials and methods for making it
12/02/1999WO1999061614A2 Human socs proteins
12/02/1999WO1999061612A1 Tumor suppressor
12/02/1999WO1999061609A1 Calmodulin related protein
12/02/1999WO1999061601A2 Aav5 vector and uses thereof
12/02/1999WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999WO1999061584A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
12/02/1999WO1999061579A2 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE
12/02/1999WO1999061477A2 Monoclonal antibody and assay for detecting piiinp
12/02/1999WO1999061475A1 Method for separating and/or isolating plasma proteins by annularchromatography
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061470A1 Respiratory nitrate reductase alpha subunit
12/02/1999WO1999061469A2 Prostate growth-associated membrane proteins
12/02/1999WO1999061468A2 The induction of antibiotic peptides by lait (scd14) protein
12/02/1999WO1999061463A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999WO1999061459A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999WO1999061453A2 priA
12/02/1999WO1999061452A2 acpS
12/02/1999WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999WO1999061057A2 Molecules targeting cd40 and tumor cells
12/02/1999WO1999061054A1 Nicotine immunogen
12/02/1999WO1999061044A1 Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
12/02/1999WO1999061040A2 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE
12/02/1999WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999WO1999060846A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies
12/02/1999WO1999053958A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
12/02/1999WO1999051745A3 Dna immunization against chlamydia infection
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999043703A8 Method for immunochemically assaying anti-hm1.24 antibody
12/02/1999WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999DE19823814A1 Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie A process for the separation and / or isolation of proteins with plasma of annular chromatography
12/02/1999CA2745939A1 Mara family helix-turn-helix domains and their methods of use
12/02/1999CA2745131A1 Aav5 vector and uses thereof
12/02/1999CA2372411A1 Method for separating and/or isolating plasma proteins by annular chromatography
12/02/1999CA2333316A1 Method for separating and/or isolating plasma proteins by annularchromatography
12/02/1999CA2333006A1 Calmodulin related protein
12/02/1999CA2332336A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies
12/02/1999CA2329694A1 Kunitz domain polypeptide and materials and methods for making it
12/02/1999CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999CA2329274A1 Interleukin-21
12/02/1999CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999CA2328905A1 Prostate growth-associated membrane proteins
12/02/1999CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999CA2328892A1 Tumor suppressor
12/02/1999CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999CA2325462A1 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
1 ... 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 ... 1494